In September 2022, global biotech giant Moderna marked a milestone by establishing its Taiwan subsidiary, naming Joyce Lee, a seasoned pharmaceutical executive, as its General Manager. Taiwan now joins Moderna’s top 10 strategic markets worldwide.
 
With 25 years of experience in multinational pharma, Joyce has risen through the ranks—from sales and marketing to leading four global pharma subsidiaries. Her journey is a true career playbook for aspiring leaders in the pharmaceutical industry.
 
At Moderna Taiwan, Joyce's mission includes:
- Addressing evolving COVID-19 variants with next-gen vaccines
- Introducing groundbreaking mRNA therapies to Taiwan
- Strengthening Taiwan's role in R&D, clinical trials, and CMO/CDMO partnerships
 
Her leadership is set to position Taiwan at the forefront of mRNA-driven medical innovation, paving the way for transformative healthcare solutions.
 
Follow #Globalbio for more stories of trailblazers shaping the future of biotech!
#ModernaTaiwan #mRNAInnovation #PharmaLeadership #BiotechRevolution